Pharmacology PRITE Review (JB PPT) Part 1 Flashcards
What is the first pass effect?
Phenomenon in which a drug gets metabolized at a specific location in the body that results in a reduced concentration of the active drug upon reaching its site of action or the systemic circulation
How does Phase 1 metabolism occur? Phase 2?
Phase 1 - CYP450 enzymes (i.e., via oxidation)
Phase 2 - Glucuronidation
What is the difference between a pharmacodynamic vs. pharmacokinetic interaction?
Dynamic - alteration due to changes in drug binding to a receptor site
Kinetic - alteration due to changes in absorption, distribution, metabolism, or excretion
Important considerations of drug metabolism in the elderly?
- Elderly patients have a decreased GFR
- Decreased liver Phase 1 oxidation (CYP enzymes)
- Absorption is UNCHANGED
Important considerations of drug metabolism in newborns?
- Drug absorption and transportation is equivalent to adults at approximately 4 months old
- GFR and CYP enzymes in children are equivalent to adults at approximately 1 year old
- Immediately after birth, babies have a lower GFR than adults, but it increases rapidly
Important considerations of drug metabolism in pregnant women?
- Increased GFR and renal blood flow rate
- Increased blood volume and cardiac output (by 30-50%)
List key landmark drug trials in psychiatry.
- CATIE trial
- STAR*D trial
- COMBINE trial
- 1999 Multimodal Treatment Study of kids of ADHD
Medications involved in CATIE trial + key finding?
Olanzapine, perphenazine, quetiapine, risperidone, ziprasidone
Olanzapine was more effective at reducing agitation, hostility, aggression
Key findings of STAR*D trial?
- Depression study
- Only about 1/3 of patients remit with first antidepressant
- Typical placebo response is also ~30%
- Bupropion augmentation is more effective and better tolerated than buspirone
Key findings of COMBINE trial?
Any combination of therapies including CBI, naltrexone, or both performed better than any combination that did not include these interventions.
Acamprosate fared poorly compared to various combinations of naltrexone/CBI.
Key finding of 1999 Multimodal Treatment Study of kids with ADHD?
Medication alone = medication + psychosocial interventions.
List FDA-approved medications for the treatment of MDD (MAOIs - 4).
- Isocarboxazid
- Phenelzine
- Selegiline (MAO-B selective)
- Tranylcypromine
List FDA-approved medications for the treatment of MDD (TCAs - 7).
- Amitriptyline
- Clomipramine
- Desipramine
- Doxepin
- Imipramine
- Nortriptyline
- Trimipramine
List FDA-approved medications for the treatment of MDD (TeCAs - tetracyclic antidepressants - 3).
- Amoxapine
- Maprotiline
- Mirtazapine
List FDA-approved medications for the treatment of MDD (NDRI - norepinephrine-dopamine reuptake inhibitors - 1).
- Bupropion
List FDA-approved medications for the treatment of MDD (SSRIs - 6).
- Citalopram
- Escitalopram
- Fluoxetine
- Fluvoxamine
- Paroxetine
- Sertraline
List FDA-approved medications for the treatment of MDD (SNRIs - 4).
- Desvenlafaxine
- Duloxetine
- Levomilnacipran
- Venlafaxine
List FDA-approved medications for the treatment of MDD (SRI/SRMs - serotonin reuptake inhibitors/modulators).
- Nefazodone
- Trazodone
- Vilazodone
- Vortioxetine
Augmentation options for the treatment of depression (6)?
- Bupropion
- Atypical antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone)
- Buspirone
- Lithium
- Liothyronine (T3)
- Mirtazapine
MDD with atypical features?
A. Mood reactivity (mood brightens in response to positive events)
B. 2 or more of the following:
1. Hypersomnia
2. Increased appetite/weight gain
3. Leaden paralysis (heavy feeling in arms and legs)
4. Interpersonal rejection sensitivity (persistent lifelong trait that may be exacerbated during periods of depression; characterized by sensitivity to rejection and/or criticism)
Key treatment of atypical depression?
MAOI
MDD with melancholic features?
A. One of the following is present during the most severe period of the current episode:
- Loss of pleasure in all, or almost all, activities
- Lack of reactivity to usually pleasurable stimuli (does not feel much better, even temporarily, when something good happens)
B. 3+ of the following:
- Distinct quality of depressed mood characterized by profound despondency, despair, and/or moroseness or by so-called empty mood
- Depression worse in the morning
- Early-morning awakening (at least 2 hours before usual)
- Marked PMA/PMR
- Significant anorexia or weight loss
- Excessive or inappropriate guilt
List the selective MAOIs.
MAO-A: clorgiline and moclobedmie
MAO-B: selegiline (at low doses)
List the non-selective MAOIs.
Isocarboxazid, phenelzine, selegiline (at high doses), tranylcypromine